The Regional Patient and Family Meetings are free educational events, designed for brain tumor patients, caregivers and their loved ones to learn, gain support and build a community. Attendees will hear
AMERICAN BRAIN TUMOR ASSOCIATION Notice of Privacy Practices Effective as of October 1, 2023 THIS NOTICE DESCRIBES HOW INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED. PLEASE REVIEW IT CAREFULLY.
The ABTA is committed to making brain tumor patient and caregiver support resources available in every community. As part of that effort, we offer brain tumor support group facilitator training
The Regional Patient and Family Meetings are free educational events, designed for brain tumor patients, caregivers and their loved ones to learn, gain support and build a community. Attendees will hear
[gravityform id=”28″ title=”false” description=”false”]
A first-of-its-kind, cross-sectional survey of patients, caregivers and physicians on the diagnosis and treatment of brain metastases, conducted by the American Brain Tumor Association (ABTA), as part of its Metastatic Brain Tumor Initiative, revealed disparities in practice patterns and communication around metastatic brain tumors. These data highlight the need to increase accessibility to clinical trials, establish clear standards of care and improve physician-patient communication reflective of the unique needs of patients with brain metastases (BM). The survey results have been published open access in the journal Neuro-Oncology Practice.
The ABTA surveyed patients, caregivers and physicians on the diagnosis and treatment of brain metastases and found disparities in care and communication. Published in the journey Neuro-Oncology Practice, this data highlight the needs of metastatic brain tumor patients.
What drives us to share our journey with a brain tumor diagnosis? The answer includes the physical and emotional benefits, and beyond. Dive deeper into this topic with the ABTA Patient Services Team and Steve, a nine-year brain tumor survivor.
WELCOME TO THE MINDMATTERS ASCO EDITION In 2019, it is estimated that 86,970 new cases of primary malignant and non-malignant brain and other central nervous system tumors will be diagnosed
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
